This is portrayed in a recent study that demonstrated co-treatment of sildenafil with chemotherapy, doxorubicin, to enhance cell cytotoxicity by inhibiting NF-κB in prostate cancer cells [70]. The gene discussed is NFKB1; the disease is Familial prostate cancer.